相似文献
1
Discovery of novel selective serotonin reuptake inhibitors through development of a protein-based pharmacophore.
J Chem Inf Model. 2011 Sep 26;51(9):2417-26. doi: 10.1021/ci200280m. Epub 2011 Sep 2.
2
Identification of novel serotonin reuptake inhibitors targeting central and allosteric binding sites: A virtual screening and molecular dynamics simulations study.
J Mol Graph Model. 2017 Jun;74:193-202. doi: 10.1016/j.jmgm.2017.02.001. Epub 2017 Mar 22.
3
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.
Nature. 2019 May;569(7754):141-145. doi: 10.1038/s41586-019-1135-1. Epub 2019 Apr 24.
4
Discovery of novel histamine H4 and serotonin transporter ligands using the topological feature tree descriptor.
J Chem Inf Model. 2012 Jan 23;52(1):233-42. doi: 10.1021/ci2004972. Epub 2011 Dec 28.
5
Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).
Mol Pharmacol. 2014 May;85(5):703-14. doi: 10.1124/mol.113.091249. Epub 2014 Feb 10.
6
Careful Examination of a Novel Azobenzene Paroxetine Derivative and Its Interactions With Biogenic Amine Transporters.
J Neurochem. 2025 Apr;169(4):e70068. doi: 10.1111/jnc.70068.
7
The chicken serotonin transporter discriminates between serotonin-selective reuptake inhibitors. A species-scanning mutagenesis study.
J Biol Chem. 2004 Oct 1;279(40):42147-56. doi: 10.1074/jbc.M405579200. Epub 2004 Jul 22.
8
Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
J Med Chem. 2002 Apr 25;45(9):1930-41. doi: 10.1021/jm0105373.
9
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
Science. 2007 Sep 7;317(5843):1390-3. doi: 10.1126/science.1147614. Epub 2007 Aug 9.
10
Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding.
J Biol Chem. 2021 Jul;297(1):100863. doi: 10.1016/j.jbc.2021.100863. Epub 2021 Jun 9.
引用本文的文献
1
PharmRL: pharmacophore elucidation with deep geometric reinforcement learning.
BMC Biol. 2024 Dec 31;22(1):301. doi: 10.1186/s12915-024-02096-5.
2
Perry Disease: Current Outlook and Advances in Drug Discovery Approach to Symptomatic Treatment.
Int J Mol Sci. 2024 Oct 3;25(19):10652. doi: 10.3390/ijms251910652.
3
PharmRL: Pharmacophore elucidation with Deep Geometric Reinforcement Learning.
Res Sq. 2024 Sep 24:rs.3.rs-5033986. doi: 10.21203/rs.3.rs-5033986/v1.
4
Unlocking the Potential of High-Quality Dopamine Transporter Pharmacological Data: Advancing Robust Machine Learning-Based QSAR Modeling.
bioRxiv. 2024 Mar 11:2024.03.06.583803. doi: 10.1101/2024.03.06.583803.
5
Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development.
Pharmaceuticals (Basel). 2023 Feb 18;16(2):317. doi: 10.3390/ph16020317.
6
Differentiated HT22 cells as a novel model for screening of serotonin reuptake inhibitors.
Front Pharmacol. 2023 Jan 10;13:1062650. doi: 10.3389/fphar.2022.1062650. eCollection 2022.
7
In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters.
ACS Omega. 2022 Oct 21;7(43):38311-38321. doi: 10.1021/acsomega.2c02714. eCollection 2022 Nov 1.
8
Application of In Silico Filtering and Isothermal Titration Calorimetry for the Discovery of Small Molecule Inhibitors of MDM2.
Pharmaceuticals (Basel). 2022 Jun 16;15(6):752. doi: 10.3390/ph15060752.
9
An Application of Fit Quality to Screen MDM2/p53 Protein-Protein Interaction Inhibitors.
Molecules. 2018 Dec 1;23(12):3174. doi: 10.3390/molecules23123174.
10
Structure and Dynamics Study of LeuT Using the Markov State Model and Perturbation Response Scanning Reveals Distinct Ion Induced Conformational States.
J Phys Chem B. 2016 Aug 25;120(33):8361-8. doi: 10.1021/acs.jpcb.6b02053. Epub 2016 Jun 30.
本文引用的文献
1
Identification of a novel selective serotonin reuptake inhibitor by coupling monoamine transporter-based virtual screening and rational molecular hybridization.
ACS Chem Neurosci. 2011 Jun 8;2(9):544-552. doi: 10.1021/cn200044x.
2
Receptor-Based Discovery of a Plasmalemmal Monoamine Transporter Inhibitor via High Throughput Docking and Pharmacophore Modeling.
ACS Chem Neurosci. 2010 Mar 17;1(3):223-233. doi: 10.1021/cn900032u.
3
Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures.
Nat Struct Mol Biol. 2009 Jun;16(6):652-7. doi: 10.1038/nsmb.1602. Epub 2009 May 10.
4
Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation.
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5563-8. doi: 10.1073/pnas.0811322106. Epub 2009 Mar 23.
5
Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.
J Biol Chem. 2009 Apr 10;284(15):10276-84. doi: 10.1074/jbc.M806907200. Epub 2009 Feb 12.
6
Managing protein flexibility in docking and its applications.
Drug Discov Today. 2009 Apr;14(7-8):394-400. doi: 10.1016/j.drudis.2009.01.003. Epub 2009 Feb 3.
7
A competitive inhibitor traps LeuT in an open-to-out conformation.
Science. 2008 Dec 12;322(5908):1655-61. doi: 10.1126/science.1166777.
8
Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation.
J Am Chem Soc. 2008 Mar 26;130(12):3853-65. doi: 10.1021/ja076403h. Epub 2008 Mar 4.
9
Three-dimensional quantitative structure-activity relationship (3D QSAR) and pharmacophore elucidation of tetrahydropyran derivatives as serotonin and norepinephrine transporter inhibitors.
J Comput Aided Mol Des. 2008 Jan;22(1):1-17. doi: 10.1007/s10822-007-9146-7. Epub 2007 Dec 4.
10
Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands.
J Mol Graph Model. 2008 Apr;26(7):1113-24. doi: 10.1016/j.jmgm.2007.10.003. Epub 2007 Oct 9.
Zotero 插件